[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337445-105":59,"doc-detail-337445-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pan-cancer-analyses-of-bromodomain-containing-9-as-a-novel-therapeutic-target-reveals-its-diagnostic-prognostic-potential-and-biological-mechanism-in-human-tumours","Pan-cancer analyses of bromodomain containing 9 as a novel therapeutic target reveals its diagnostic, prognostic potential and biological mechanism in human tumours","","This research article investigates bromodomain containing 9 (BRD9) as a novel therapeutic target across multiple cancer types. It evaluates BRD9 expression using comprehensive pan-cancer bioinformatics analyses based on The Cancer Genome Atlas, followed by experimental validation in tissue microarrays and lung/colon cancer cell lines. Findings show elevated BRD9 expression, distinct diagnostic and prognostic value via survival data and DNA methylation, and mechanistic links to mRNA splicing and molecular binding, suggesting biomarker and therapeutic potential.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pan-cancer-analyses-of-bromodomain-containing-9-as-a-novel-therapeutic-target-reveals-its-diagnostic-prognostic-potential-and-biological-mechanism-in-human-tumours/337445/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pan-cancer-analyses-of-bromodomain-containing-9-as-a-novel-therapeutic-target-reveals-its-diagnostic-prognostic-potential-and-biological-mechanism-in-human-tumours/337445.png","ImageObject",300,407,{"name":92,"@type":93},"Himbo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is BRD9 and why is it studied in this work?","Question",{"text":112,"@type":113},"BRD9 is a recently identified gene encoding a protein involved in SWI/SNF chromatin-remodelling complexes. The study focuses on its diagnostic, prognostic, and biological mechanism potential across human cancers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were BRD9 expression and pan-cancer patterns analyzed?",{"text":117,"@type":113},"The study used multiple bioinformatics tools to generate comprehensive pan-cancer analyses of BRD9 expression across disease types described in The Cancer Genome Atlas (TCGA).",{"name":119,"@type":110,"acceptedAnswer":120},"What experimental evidence supports the computational findings?",{"text":121,"@type":113},"Experimental validation was conducted using tissue microarrays and cell lines derived from lung and colon cancers, confirming functional relevance of BRD9 in those contexts.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337445,1790334536,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":26,"preview_page_count":19,"preview_urls":145},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","DOI: 10.1002/ctm2.1543  \nRESEARCH ARTICLE  \nPan-cancer analyses of bromodomain containing 9 as a novel therapeutic target reveals its diagnostic, prognostic potential and biological mechanism in human tumours  \nYu Chen1,2   Zitong Gao1,2  Isam Mohd-Ibrahim1, 2  Hua Yang1  Lang Wu3   Yuanyuan Fu1  Youping Deng1   \n1 Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii, USA  \n2 Department of Molecular Biosciencesand Bioengineering, College of Tropical Agriculture and Human Resources, Agricultural Sciences, University of Hawaii at Manoa, Honolulu, Hawaii, USA  \n3 Cancer Epidemiology Division, Population Sciences in the Pacific Program, University of Hawaii Cancer Center, University of Hawaii at Manoa, Honolulu, Hawaii, USA  \nCorrespondence  \nYouping Deng, Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii at Manoa, 651Ilalo Street, Honolulu, HI, USA. [Email:](Email: dengy@hawaii.edu)[ dengy@hawaii.edu](Email: dengy@hawaii.edu)  \nYuanyuan Fu, Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii atManoa, 651Ilalo Street, Honolulu, HI, USA.  \nEmail: [fuy@hawaii.edu](fuy@hawaii.edu)  \nGraphical Abstract  \n1. The pan-cancer analyses of bromodomain containing 9 (BRD9) provided a comprehensive perspective for the development of BRD9-based targeted therapies for a variety of different cancers.  \n2. BRD9 may affect cancer progression through different phosphorylation sites or N6-methyladenosine site modifications.  \n3. BRD9 could be used as a novel biomarker for diagnosis of multiple cancer types.  \n4. Our functional study of BRD9 showed interaction with SMARCD1 . Knockdown of BRD9 could inhibit the progression of lung and colon cancers through the Wnt/β-catenin signalling pathway.  \nClin. Transl. Med. 2024;14:e1543 .  \n[https://doi.org/10.1002/ctm2.1543](https://doi.org/10.1002/ctm2.1543)  \n[wileyonlinelibrary.com/journal/ctm2](wileyonlinelibrary.com/journal/ctm2)  \nDOI: 10.1002/ctm2.1543  \nRESEARCH ARTICLE  \nPan-cancer analyses of bromodomain containing 9 as a novel therapeutic target reveals its diagnostic, prognostic potential and biological mechanism in human tumours  \nYu Chen1,2   Zitong Gao1,2  Isam Mohd-Ibrahim1, 2  Hua Yang1  Lang Wu3   Yuanyuan Fu1  Youping Deng1   \n1 Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii, USA  \n2 Department of Molecular Biosciencesand Bioengineering, College of Tropical Agriculture and Human Resources, Agricultural Sciences, University of Hawaii at Manoa, Honolulu, Hawaii, USA  \n3 Cancer Epidemiology Division, Population Sciences in the Pacific Program, University of Hawaii Cancer Center, University of Hawaii at Manoa, Honolulu, Hawaii, USA  \nCorrespondence  \nYouping Deng, Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii at Manoa, 651Ilalo Street, Honolulu, HI, USA. [Email:](Email: dengy@hawaii.edu)[ dengy@hawaii.edu](Email: dengy@hawaii.edu)  \nYuanyuan Fu, Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii at Manoa, 651Ilalo Street, Honolulu, HI, USA.  \nEmail: [fuy@hawaii.edu](fuy@hawaii.edu)  \nFunding information  \nAmerican Association for Cancer Research, Grant/Award Number:  \n22-40-68-FU; National Institutes of Health, Grant/Award Numbers:  \nAbstract  \nBackground: Mutations in one or more genes responsible for encoding subunits within the SWItch/Sucrose Non-Fermentable (SWI/SNF) chromatinremodelling complexes are found in approximately 25% of cancer patients. Bromodomain containing 9 (BRD9) is a more recently identified protein coding gene, which can encode SWI/SNF chromatin-remodelling complexes subunits. Although initial evaluations of the potential of BRD9-based targeted therapy have been explored in the clinical application of a small number of cancer types","cbCaiba5ymERqFAp","https://ap.wps.com/l/cbCaiba5ymERqFAp","pdf",13108759,24,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion and Implications","[{\"question\":\"What is BRD9 and why is it studied in this work?\",\"answer\":\"BRD9 is a recently identified gene encoding a protein involved in SWI/SNF chromatin-remodelling complexes. The study focuses on its diagnostic, prognostic, and biological mechanism potential across human cancers.\"},{\"question\":\"How were BRD9 expression and pan-cancer patterns analyzed?\",\"answer\":\"The study used multiple bioinformatics tools to generate comprehensive pan-cancer analyses of BRD9 expression across disease types described in The Cancer Genome Atlas (TCGA).\"},{\"question\":\"What experimental evidence supports the computational findings?\",\"answer\":\"Experimental validation was conducted using tissue microarrays and cell lines derived from lung and colon cancers, confirming functional relevance of BRD9 in those contexts.\"}]","Pan-cancer analyses of bromodomain containing 9 as a novel therapeutic target reveals its diagnostic, prognostic potential and biological mechanism in human tumours | PDF",1790019176,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b458d8b867b7144c7f916c264da84988.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/30fd0461fc10b7f39270fccaf46c0ba3.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f076d1e830dd744e2e2fb2650ff01c4f.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4b33f1113f790d729f1e86f56982e675.webp",980,1287]